This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
200053 |
4. Check minimum number of eventsNone |
200053 |
5. Include endpoints |
204344 |
6. Filter based on genotype QC (FinnGen only) |
204344 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 1
- First used in FinnGen datafreeze
- DF10
Neurological diseases
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 204344 | 112797 | 91547 |
| Unadjusted period prevalence (%) | 39.30 | 38.45 | 40.36 |
| Median age at first event (years) | 53.43 | 50.85 | 56.62 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1569
- Matched controls
- 9551
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
+∞
254.6
287
*
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
16.8
154.4
290
127
G43.9
ICD-10 Finland
Migraine, unspecified
18.6
133.6
241
92
N03AF02
ATC
oxcarbazepine; oral
184.5
131.8
163
6
G47.3
ICD-10 Finland
Sleep apnoea
29.4
131.1
207
49
N03AG01
ATC
valproic acid; systemic, rectal
20.5
129.9
227
78
G40.9
ICD-10 Finland
Epilepsy, unspecified
342.6
127.4
153
*
R56.8
ICD-10 Finland
Other and unspecified convulsions
9.1
113.0
283
226
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
10.6
112.9
259
175
N03AX14
ATC
levetiracetam; systemic
123.1
101.9
130
7
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
782.8
100.9
119
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
8.5
99.1
256
213
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
6.5
91.7
287
319
R51.80
ICD-10 Finland
Headache
4.7
90.1
387
628
G44.2
ICD-10 Finland
Tension-type headache
7.9
86.0
232
205
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
6.5
79.7
248
270
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
10.5
75.2
171
110
N05CD08
ATC
midazolam; nasal, systemic
66.3
74.9
102
10
N05BA09
ATC
clobazam; oral
525.7
68.7
82
*
183
Kela drug reimbursment
Lamotrigin and topiramate
+∞
66.2
77
*
N03AX11
ATC
topiramate; oral
61.5
62.5
86
9
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
+∞
59.3
69
*
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
+∞
54.9
64
*
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
+∞
54.9
64
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
5.8
52.6
174
201
C09CA06
ATC
candesartan; oral
9.6
52.1
123
84
N02BE01
ATC
paracetamol; systemic, rectal
2.3
51.9
888
3442
R5140
NOMESCO Finland
Monitoring the use of the aid
25.6
51.8
84
21
AA1AD
NOMESCO Finland
CT of head and brain
4.9
49.4
190
262
G40.4
ICD-10 Finland
Other generalized epilepsy and epileptic syndromes
+∞
48.9
57
*
G40.39
ICD-10 Finland
Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures
+∞
48.0
56
*
XA800
NOMESCO Finland
Neuropsychological investigation
6.0
46.1
147
161
TAB00
NOMESCO Finland
Lumbar puncture
9.7
45.3
106
71
R4110
NOMESCO Finland
Physiotherapy
2.9
43.5
333
814
G43
ICD-10 Finland
Migraine
5.5
43.4
149
179
C07AB07
ATC
bisoprolol; oral
5.0
43.4
161
212
G43.3
ICD-10 Finland
Complicated migraine
115.5
42.8
55
*
N88
ICPC
Epilepsy
+∞
42.8
50
*
C07AA05
ATC
propranolol; systemic
3.2
40.4
259
558
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.6
40.1
384
1070
N03AX09
ATC
lamotrigine; oral
6.3
39.2
120
124
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
8.6
38.3
95
71
N05BA01
ATC
diazepam; systemic, rectal
4.6
37.2
148
210
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
+∞
36.8
43
*
Z2445
NOMESCO Finland
Psychologist
3.2
34.5
217
458
G40.10
ICD-10 Finland
Simple partial seizures
261.6
34.4
42
*
N89
ICPC
Migraine
4.2
34.3
151
237
WX780
NOMESCO Finland
Remote monitoring CPAP
+∞
33.3
39
*
A02BC02
ATC
pantoprazole; systemic
2.4
33.2
367
1088
M03BX02
ATC
tizanidine; oral
2.6
33.1
291
762
N02CC04
ATC
rizatriptan; oral
11.3
33.1
71
40
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.6
32.4
289
762
Z2221
NOMESCO Finland
Medical doctor
2.4
31.9
335
967
ZXE10
NOMESCO Finland
More than one and less than three hours
2.3
31.7
385
1194
A03FA01
ATC
metoclopramide; systemic, rectal
4.4
31.5
130
191
Z3226
NOMESCO Finland
Physiotherapist
2.5
31.3
292
788
G43.8
ICD-10 Finland
Other migraine
36.0
30.9
46
8
N06AX11
ATC
mirtazapine; oral
2.7
30.3
253
641
N03AG04
ATC
vigabatrin; oral
+∞
29.9
35
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.2
29.5
385
1230
Z3231
NOMESCO Finland
Registered nurse
2.1
29.5
471
1643
N03AX12
ATC
gabapentin; oral
7.2
29.4
81
72
WX723
NOMESCO Finland
CPAP therapy
223.1
29.3
36
*
G40.89
ICD-10 Finland
Other epilepsy
+∞
29.1
34
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.9
28.5
199
449
R53
ICD-10 Finland
Malaise and fatigue
2.7
28.3
235
591
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.1
26.9
174
373
3007
Kela drug reimbursment
Erenumab and fremanezumab
203.9
26.7
33
*
N03AX18
ATC
lacosamide; systemic
203.9
26.7
33
*
G80.1
ICD-10 Finland
Spastic diplegic cerebral palsy
+∞
26.5
31
*
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
+∞
26.5
31
*
N05AH04
ATC
quetiapine; oral
2.3
26.0
284
827
G51.0
ICD-10 Finland
Bell palsy
197.6
25.9
32
*
R42
ICD-10 Finland
Dizziness and giddiness
3.3
25.9
151
300
R4120
NOMESCO Finland
Occupational therapy
4.2
25.8
110
167
G80.2
ICD-10 Finland
Spastic hemiplegic cerebral palsy
+∞
25.6
30
*
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
+∞
25.6
30
*
N02CC07
ATC
frovatriptan; oral
16.9
25.4
46
17
TPH04
NOMESCO Finland
Cathetrisation of vein
2.6
25.2
212
535
N03AX16
ATC
pregabalin; oral
4.2
25.2
108
165
XF400
NOMESCO Finland
ECG with 12 standard connections
2.6
24.6
217
563
G47.9
ICD-10 Finland
Sleep disorder, unspecified
11.8
24.5
51
27
Z2446
NOMESCO Finland
Social worker
2.5
24.0
223
595
G40
ICD-10 Finland
Epilepsy
+∞
23.9
28
*
181
Kela drug reimbursment
Retigabine and vigabatrin
+∞
23.9
28
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.2
23.8
289
882
ZXE00
NOMESCO Finland
One hour or less
1.9
23.4
501
1917
N06AB10
ATC
escitalopram; oral
2.2
23.4
283
862
ZY010
NOMESCO Finland
Hospital outpatient
2.6
23.4
204
525
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.3
23.4
267
792
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
4.5
23.2
92
130
G40.09
ICD-10 Finland
Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset
+∞
23.0
27
*
G40.11
ICD-10 Finland
Simple partial epileptic seizure that develops into a complex partial seizure
+∞
23.0
27
*
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
9.5
23.0
53
35
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.5
22.8
211
561
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
22.7
387
1360
Z01.8
ICD-10 Finland
Other specified special examinations
2.3
22.6
245
706
G41.9
ICD-10 Finland
Status epilepticus, unspecified
174.0
22.5
28
*
M01AE01
ATC
ibuprofen; systemic, rectal
1.7
22.3
1016
4909
N01
ICPC
Headache
1.8
22.3
557
2240
ZXD05
NOMESCO Finland
Urgent procedure
2.1
22.2
324
1070
N02CC06
ATC
eletriptan; oral
12.2
22.0
45
23
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
11.7
21.7
45
24
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.8
21.6
467
1783
ZXE20
NOMESCO Finland
More than three and less than five hours
2.7
21.1
170
418
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
37.2
20.4
30
5
N05BA04
ATC
oxazepam; oral
2.6
20.3
168
419
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.0
19.9
290
953
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.4
19.7
108
204
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.7
19.7
153
367
G91.1
ICD-10 Finland
Obstructive hydrocephalus
+∞
19.6
23
*
M79.6
ICD-10 Finland
Pain in limb
1.9
19.6
340
1196
R55
ICD-10 Finland
Syncope and collapse
3.2
19.1
114
229
G25.8
ICD-10 Finland
Other specified extrapyramidal and movement disorders
+∞
18.8
22
*
Z3229
NOMESCO Finland
Other healthcare associate professional
2.7
18.8
142
336
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.5
18.6
163
419
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.1
18.5
240
750
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
3.3
18.1
103
199
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
7.8
18.0
46
37
N02CC03
ATC
zolmitriptan; nasal, oral
6.8
17.9
50
46
N03AX22
ATC
perampanel; oral
+∞
17.9
21
*
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
+∞
17.9
21
*
N02CD01
ATC
erenumab; parenteral
135.7
17.5
22
*
N05AX08
ATC
risperidone; systemic
2.8
17.4
125
286
RT150
NOMESCO Finland
NA
18.6
17.3
30
10
N03AF01
ATC
carbamazepine; oral, rectal
32.2
17.3
26
5
R51
ICD-10 Finland
Headache
3.1
17.2
106
219
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.7
17.2
83
142
S06.0
ICD-10 Finland
Concussion
2.1
17.1
236
754
R06.5
ICD-10 Finland
Mouth breathing
3.0
17.0
110
234
ZXD10
NOMESCO Finland
Scheduled procedure
1.7
16.7
409
1602
A02BC05
ATC
esomeprazole; systemic
2.3
16.6
169
469
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.9
16.6
271
926
WX892
NOMESCO Finland
Monitored bed care
3.0
16.4
107
228
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.1
16.2
213
666
G40.00
ICD-10 Finland
Benign childhood epilepsy with centrotemporal EEG spikes
+∞
16.2
19
*
L01
ICPC
Neck symptom/complaint
2.2
16.1
194
585
F51.0
ICD-10 Finland
Nonorganic insomnia
2.4
15.8
148
394
N02CD03
ATC
fremanezumab; systemic
123.2
15.8
20
*
N06AB03
ATC
fluoxetine; oral
2.4
15.5
146
389
G56.0
ICD-10 Finland
Carpal tunnel syndrome
10.0
15.4
34
21
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
+∞
15.3
18
*
G80.9
ICD-10 Finland
Cerebral palsy, unspecified
+∞
15.3
18
*
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
+∞
15.3
18
*
N03AX15
ATC
zonisamide; oral
+∞
15.3
18
*
G47.4
ICD-10 Finland
Narcolepsy and cataplexy
+∞
15.3
18
*
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.9
15.3
256
879
G44.8
ICD-10 Finland
Other specified headache syndromes
12.0
15.3
31
16
ZXA05
NOMESCO Finland
Left side
2.3
15.3
157
439
AA7AA
NOMESCO Finland
Liquor cerebri shunt X-ray examinatin without contrast
117.0
15.0
19
*
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
117.0
15.0
19
*
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
5.2
14.8
50
60
F90.0
ICD-10 Finland
Disturbance of activity and attention
2.1
14.7
180
546
N02AX02
ATC
tramadol; systemic, rectal
2.2
14.5
167
492
A02BC01
ATC
omeprazole; systemic
2.4
14.5
133
351
XF404
NOMESCO Finland
Ambulatory ECG
3.2
14.5
85
170
M25.5
ICD-10 Finland
Pain in joint
1.9
14.4
254
888
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
14.4
180
550
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.3
14.4
150
421
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
3.1
14.3
85
172
N06AX16
ATC
venlafaxine; oral
2.4
14.3
134
358
N03AE01
ATC
clonazepam; systemic
7.4
14.2
37
31
L28
ICPC
Limited function/disability (L)
2.9
14.2
98
218
M01AE03
ATC
ketoprofen; systemic, rectal
2.9
14.2
98
218
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
8.4
14.1
34
25
WX402
NOMESCO Finland
General anaesthesia
2.0
14.1
221
740
F93.89
ICD-10 Finland
Other childhood emotional disorders
3.0
14.1
88
184
M01AE02
ATC
naproxen; oral, rectal
1.5
14.1
877
4329
N06AX21
ATC
duloxetine; oral
3.7
13.9
67
115
R11
ICD-10 Finland
Nausea and vomiting
2.3
13.8
147
417
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
6.1
13.8
41
42
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.5
13.8
120
308
Z31.5
ICD-10 Finland
Genetic counselling
2.7
13.7
102
237
G35
ICD-10 Finland
Multiple sclerosis
+∞
13.6
16
*
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
+∞
13.6
16
*
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
9.1
13.5
31
21
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.4
13.4
126
337
G54.0
ICD-10 Finland
Brachial plexus disorders
25.9
13.4
21
5
N02AJ06
ATC
codeine and paracetamol; systemic
1.8
13.4
297
1120
P06
ICPC
Sleep disturbance
2.2
13.4
157
467
M03BC01
ATC
orphenadrine (citrate); systemic
2.7
13.4
98
228
P85
ICPC
Mental retardation
8.3
13.2
32
24
Z71.8
ICD-10 Finland
Other specified counselling
1.7
13.2
357
1429
SPAT1240
SPAT
Therapeutic discussion
1.8
12.9
238
846
G47.2
ICD-10 Finland
Disorders of the sleep-wake schedule
+∞
12.8
15
*
N03AX23
ATC
brivaracetam; systemic
+∞
12.8
15
*
G25.0
ICD-10 Finland
Essential tremor
15.8
12.7
23
9
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
2.9
12.6
82
176
M54.5
ICD-10 Finland
Low back pain
1.8
12.5
243
875
X59
ICD-10 Finland
Exposure to unspecified factor
1.8
12.5
271
1013
R5599
NOMESCO Finland
Other rehabilitation service
3.8
12.5
56
91
WX704
NOMESCO Finland
Intubation
3.2
12.4
71
140
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
2.8
12.4
89
204
M41.4
ICD-10 Finland
Neuromuscular scoliosis
36.9
12.4
18
*
L11
ICPC
Wrist symptom/complaint
1.9
12.3
215
747
F83
ICD-10 Finland
Mixed specific developmental disorders
2.8
12.2
87
198
J01DB01
ATC
cefalexin; oral
1.5
12.2
1026
5324
R62.0
ICD-10 Finland
Delayed milestone
2.7
12.2
90
209
N06BA04
ATC
methylphenidate; oral
2.2
12.1
133
382
R07.4
ICD-10 Finland
Chest pain, unspecified
2.1
12.1
154
473
M01AB05
ATC
diclofenac; systemic, rectal
1.8
12.0
256
949
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.3
11.9
65
123
TJD20
NOMESCO Finland
Change of gastrostomy tube
8.7
11.9
28
20
G40.33
ICD-10 Finland
Juvenile absence epilepsy
+∞
11.9
14
*
G91.0
ICD-10 Finland
Communicating hydrocephalus
+∞
11.9
14
*
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.0
11.9
175
569
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
11.8
921
4687
XG466
NOMESCO Finland
Sleep oxymetry
34.8
11.6
17
*
WX110
NOMESCO Finland
Local anesthesy
1.5
11.6
1037
5422
N02CC05
ATC
almotriptan; oral
6.6
11.6
32
30
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.5
11.5
58
104
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.9
11.5
77
169
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.3
11.5
115
316
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
3.5
11.4
58
105
G44.0
ICD-10 Finland
Cluster headache syndrome
19.5
11.3
19
6
JDB10
NOMESCO Finland
Percutaneous gastrostomy
9.6
11.3
25
16
N06AB06
ATC
sertraline; oral
2.0
11.3
154
488
SPAT1229
SPAT
Assessment of need for aid
5.4
11.3
36
41
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
3.3
11.2
61
115
N06AX12
ATC
bupropion; oral
2.4
11.2
106
283
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.3
11.2
111
304
XF600
NOMESCO Finland
Bloodpressure measurement
2.2
11.2
129
381
XCK00
NOMESCO Finland
Perimetry
4.6
11.2
41
55
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.8
11.1
234
863
G04.9
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis, unspecified
+∞
11.1
13
*
N03AD01
ATC
ethosuximide; oral
+∞
11.1
13
*
ADB00
NOMESCO Finland
Implantation of vagus nerve stimulating device
+∞
11.1
13
*
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.5
10.9
89
221
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.4
10.9
100
265
RS222
NOMESCO Finland
NA
6.9
10.8
29
26
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.8
10.7
199
706
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
3.1
10.7
63
126
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.2
10.6
116
332
R20.2
ICD-10 Finland
Paraesthesia of skin
3.9
10.6
46
73
SPAT1283
SPAT
Restricted health certificate
1.5
10.6
448
1989
H53.4
ICD-10 Finland
Visual field defects
18.5
10.6
18
6
L03
ICPC
Low back symptom/complaint
1.7
10.6
277
1091
K30
ICD-10 Finland
Functional dyspepsia
2.9
10.4
67
144
E66.00
ICD-10 Finland
Metabolic syndrome
6.2
10.4
30
30
G40.30
ICD-10 Finland
Benign myoclonic eplilepsy in infancy
+∞
10.2
12
*
G80.0
ICD-10 Finland
Spastic quadriplegic cerebral palsy
+∞
10.2
12
*
G81.9
ICD-10 Finland
Hemiplegia, unspecified
+∞
10.2
12
*
M53.1
ICD-10 Finland
Cervicobrachial syndrome
3.0
10.2
62
129
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
10.8
10.1
21
12
IGY02
NOMESCO Finland
Psychiatric monitoring contact
2.4
10.0
87
224
N06BA07
ATC
modafinil; oral
43.0
10.0
14
*
J01AA02
ATC
doxycycline; systemic
1.6
10.0
344
1455
N05CF01
ATC
zopiclone; oral
2.8
9.9
67
148
SPAT1249
SPAT
Treatment-related counselling outside office
1.5
9.9
505
2328
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
3.9
9.8
43
69
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
2.1
9.8
121
368
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.5
9.8
80
200
XF402
NOMESCO Finland
ECG with work load test
3.4
9.7
50
92
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
3.2
9.6
53
102
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.2
9.6
107
310
F81.8
ICD-10 Finland
Other developmental disorders of scholastic skills
4.6
9.6
35
47
F82
ICD-10 Finland
Specific developmental disorder of motor function
2.8
9.5
65
145
J01CE02
ATC
phenoxymethylpenicillin; oral
1.4
9.5
909
4715
M03BX01
ATC
baclofen; systemic
23.0
9.4
15
*
L09
ICPC
Arm symptom/complaint
2.4
9.4
87
230
E66.8
ICD-10 Finland
Other obesity
4.4
9.4
36
51
A04
ICPC
Weakness/tiredness general
1.6
9.4
248
977
G56.2
ICD-10 Finland
Lesion of ulnar nerve
14.9
9.4
17
7
G80.3
ICD-10 Finland
Dyskinetic cerebral palsy
+∞
9.4
11
*
G40.6
ICD-10 Finland
Grand mal seizures, unspecified (with or without petit mal)
+∞
9.4
11
*
282
Kela drug reimbursment
Sodium oxybat
+∞
9.4
11
*
G40.36
ICD-10 Finland
Juvenile myoclonic epilepsy [impulsive petit mal]
+∞
9.4
11
*
G93.0
ICD-10 Finland
Cerebral cysts
+∞
9.4
11
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
9.3
288
1184
ACC51
NOMESCO Finland
Release of median nerve
28.6
9.3
14
*
H02AB06
ATC
prednisolone; systemic
1.6
9.3
323
1365
R4190
NOMESCO Finland
Nutritional therapy
2.2
9.3
105
308
M03BC51
ATC
orphenadrine, combinations; systemic
2.5
9.2
74
183
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
2.1
9.2
105
309
R2110
NOMESCO Finland
Giving the first information
3.5
9.2
45
80
C03CA01
ATC
furosemide; systemic
3.3
9.2
50
95
N05AH03
ATC
olanzapine; systemic
2.1
9.2
109
327
G72.8
ICD-10 Finland
Other specified myopathies
73.6
9.2
12
*
J96.1
ICD-10 Finland
Chronic respiratory failure
73.6
9.2
12
*
AEA50
NOMESCO Finland
Adjustment of implanted neurostimulator
73.6
9.2
12
*
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
2.3
9.2
88
238
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.6
9.2
270
1095
C07AB02
ATC
metoprolol; systemic
3.6
9.1
43
74
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
13.1
8.9
17
8
P01
ICPC
Feeling anxious/nervous/tense
1.5
8.9
365
1600
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
4.1
8.9
36
54
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.4
8.9
550
2623
R4150
NOMESCO Finland
Neuropsychological rehabilitation
18.4
8.9
15
5
R03AC02
ATC
salbutamol; inhalant
1.4
8.8
685
3403
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
5.1
8.8
29
35
H03AA01
ATC
levothyroxine sodium; systemic
2.4
8.8
79
208
XA400
NOMESCO Finland
EEG
8.8
8.8
20
14
RS211
NOMESCO Finland
NA
6.4
8.7
24
23
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
8.7
659
3256
ZXA10
NOMESCO Finland
Bilateral
1.7
8.7
186
690
G93.3
ICD-10 Finland
Postviral fatigue syndrome
21.5
8.7
14
*
M79.1
ICD-10 Finland
Myalgia
2.1
8.7
109
335
NE1AA
NOMESCO Finland
Pelvis X-ray examination
3.5
8.6
42
75
M01AG02
ATC
tolfenamic acid; oral, rectal
3.3
8.6
45
85
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
7.1
8.6
22
19
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.8
8.5
150
522
R1250
NOMESCO Finland
Evaluation of functional capability
4.6
8.5
31
42
G37.9
ICD-10 Finland
Demyelinating disease of central nervous system, unspecified
+∞
8.5
10
*
109
Kela drug reimbursment
Multiple sclerosis
+∞
8.5
10
*
N03AF03
ATC
rufinamide; oral
+∞
8.5
10
*
RT274
NOMESCO Finland
NA
+∞
8.5
10
*
G71.9
ICD-10 Finland
Primary disorder of muscle, unspecified
+∞
8.5
10
*
214
Kela drug reimbursment
Severe and chronic narcolepsy
+∞
8.5
10
*
AAJ20
NOMESCO Finland
Excision of epileptic focus
+∞
8.5
10
*
F81.3
ICD-10 Finland
Mixed disorder of scholastic skills
3.9
8.5
36
57
S93.4
ICD-10 Finland
Sprain and strain of ankle
1.6
8.5
246
994
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
36.8
8.4
12
*
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
3.7
8.3
38
64
L02
ICPC
Back symptom/complaint
1.7
8.3
170
622
F43.8
ICD-10 Finland
Other reactions to severe stress
3.4
8.3
42
77
B01AA03
ATC
warfarin; systemic
4.3
8.3
32
46
SPAT1307
SPAT
Psychosocial counselling and guidance
1.6
8.2
256
1049
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
3.0
8.2
50
104
P03
ICPC
Feeling depressed
1.6
8.2
259
1067
S18
ICPC
Laceration/cut
1.4
8.2
417
1908
N06AB04
ATC
citalopram; systemic
2.6
8.2
61
145
RL140
NOMESCO Finland
NA
10.4
8.2
17
10
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.9
8.2
51
109
M01AH05
ATC
etoricoxib; oral
1.6
8.1
239
969
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
5.2
8.0
26
31
I10
ICD-10 Finland
Essential (primary) hypertension
3.1
8.0
45
89
ZYC01
NOMESCO Finland
Remote contact by phone
2.1
8.0
92
272
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.5
8.0
379
1710
EMB10
NOMESCO Finland
Tonsillectomy
1.8
8.0
137
474
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.3
7.9
77
210
N05AA02
ATC
levomepromazine; systemic
4.5
7.9
29
40
RS310
NOMESCO Finland
NA
8.5
7.8
18
13
SPAT1389
SPAT
Visit based on need for special support
1.7
7.8
184
702
N06CA01
ATC
amitriptyline and psycholeptics; systemic
6.2
7.8
22
22
FM2CE
NOMESCO Finland
NA
2.2
7.8
82
234
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.2
7.8
81
228
XX4AW
NOMESCO Finland
NA
4.4
7.7
29
41
KMAK
NOMESCO Finland
NA
1.5
7.7
283
1207
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.4
7.7
537
2600
G81.1
ICD-10 Finland
Spastic hemiplegia
+∞
7.7
9
*
D33.05
ICD-10 Finland
Other lateral benign tumor in temporal lobe
+∞
7.7
9
*
199
Kela drug reimbursment
Rufinamide
+∞
7.7
9
*
G60.0
ICD-10 Finland
Hereditary motor and sensory neuropathy
+∞
7.7
9
*
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
+∞
7.7
9
*
G40.35
ICD-10 Finland
Juvenile absence epilepsy
+∞
7.7
9
*
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
3.0
7.6
44
90
M54.4
ICD-10 Finland
Lumbago with sciatica
2.5
7.6
60
148
N18
ICPC
Paralysis/weakness
61.2
7.5
10
*
G03.9
ICD-10 Finland
Meningitis, unspecified
61.2
7.5
10
*
AAF25
NOMESCO Finland
Removal of shunt of ventricle of brain
61.2
7.5
10
*
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
9.8
7.5
16
10
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.2
7.5
80
230
M03AX01
ATC
botulinum toxin; parenteral
15.9
7.4
13
5
M53.0
ICD-10 Finland
Cervicocranial syndrome
2.8
7.4
49
107
N06AX26
ATC
vortioxetine; oral
2.1
7.4
90
273
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
2.9
7.4
46
98
IAB07
NOMESCO Finland
Consultation concerning a patient with self-harm intention
5.1
7.4
24
29
N29
ICPC
Neurological sympt/complt other
5.1
7.4
24
29
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.6
7.4
237
978
IGY99
NOMESCO Finland
Other psychiatric treatment contact
2.1
7.4
81
236
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.8
7.3
47
103
N17
ICPC
Vertigo/dizziness
1.8
7.3
131
458
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
2.7
7.3
50
114
H52.0
ICD-10 Finland
Hypermetropia
2.4
7.3
66
174
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.0
7.3
93
289
F51.9
ICD-10 Finland
Nonorganic sleep disorder, unspecified
3.6
7.3
33
56
P76
ICPC
Depressive disorder
1.9
7.3
115
386
SPAT1262
SPAT
Handing over of treatment supplies
2.2
7.2
78
225
R06.0
ICD-10 Finland
Dyspnoea
1.7
7.2
155
574
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
3.4
7.2
35
63
S60.2
ICD-10 Finland
Contusion of other parts of wrist and hand
2.0
7.2
94
294
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
2.0
7.2
96
303
M54.2
ICD-10 Finland
Cervicalgia
2.9
7.2
45
97
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
2.3
7.2
70
192
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.4
7.1
582
2886
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
1.9
7.1
105
344
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.5
7.1
284
1234
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.9
7.1
103
337
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.7
7.1
49
113
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.9
7.0
106
349
T82
ICPC
Obesity
3.1
7.0
40
81
C08DA01
ATC
verapamil; systemic
13.3
7.0
13
6
G57.3
ICD-10 Finland
Lesion of lateral popliteal nerve
22.4
7.0
11
*
SPAT1050
SPAT
Extensive neurological examination
4.0
6.9
28
43
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
2.2
6.9
69
193
R52.9
ICD-10 Finland
Pain, unspecified
2.1
6.9
80
239
N28
ICPC
Limited function/disability (N)
8.2
6.9
16
12
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.5
6.9
248
1053
R01AD12
ATC
fluticasone furoate; nasal
1.4
6.9
362
1662
R00.2
ICD-10 Finland
Palpitations
2.2
6.8
68
189
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
2.0
6.8
93
295
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
30.6
6.8
10
*
RT190
NOMESCO Finland
NA
+∞
6.8
8
*
N07XX04
ATC
sodium oxybate; oral
+∞
6.8
8
*
N03AX17
ATC
stiripentol; oral
+∞
6.8
8
*
3AX01
NOMESCO Finland
NA
+∞
6.8
8
*
AA10D
NOMESCO Finland
NA
+∞
6.8
8
*
G80.8
ICD-10 Finland
Other cerebral palsy
+∞
6.8
8
*
AAF99
NOMESCO Finland
Other shunt operation on ventricle of brain or intracerebral cyst
+∞
6.8
8
*
G40.1
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
+∞
6.8
8
*
Q04.3
ICD-10 Finland
Other reduction deformities of brain
+∞
6.8
8
*
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
4.2
6.8
26
38
W10
ICD-10 Finland
Fall on and from stairs and steps
2.8
6.8
43
94
RS140
NOMESCO Finland
NA
5.0
6.7
22
27
G55.1*M51.1
ICD-10 Finland
Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions
14.7
6.7
12
5
N05CF02
ATC
zolpidem; oral
2.7
6.7
46
105
H52.2
ICD-10 Finland
Astigmatism
2.5
6.7
54
134
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.2
6.7
65
180
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
3.3
6.7
34
64
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.3
6.7
34
64
WX730
NOMESCO Finland
Conventional respirator
4.3
6.6
25
36
UDC00
NOMESCO Finland
Ear microscopy
1.7
6.6
132
480
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
11.4
6.6
13
7
J35.1
ICD-10 Finland
Hypertrophy of tonsils
1.9
6.6
97
318
R50.9
ICD-10 Finland
Fever, unspecified
1.5
6.5
252
1084
TLC00
NOMESCO Finland
Insertion of intrauterine device
3.6
6.5
30
52
H53.1
ICD-10 Finland
Subjective visual disturbances
2.7
6.5
45
104
N99
ICPC
Neurological disease other
16.8
6.5
11
*
H47.1
ICD-10 Finland
Papilloedema, unspecified
16.8
6.5
11
*
E66.01
ICD-10 Finland
Obesity due to excess calories
2.2
6.5
68
195
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.2
6.4
65
182
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.4
6.4
53
135
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
6.5
6.4
17
16
R1260
NOMESCO Finland
Evaluation of communicative skills
3.5
6.4
30
53
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.2
6.4
67
191
J02.9
ICD-10 Finland
Acute pharyngitis, unspecified
1.6
6.4
159
616
TPH07
NOMESCO Finland
Cathetrisation of artery
2.0
6.4
84
265
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
3.3
6.3
32
60
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.7
6.3
131
482
SPAT1377
SPAT
Polysomnography
4.2
6.3
24
35
R52.2
ICD-10 Finland
Other chronic pain
4.2
6.3
24
35
PA6BG
NOMESCO Finland
MRI examination of neck vasculature with high intensity magnet
12.3
6.3
12
6
N05AX12
ATC
aripiprazole; systemic
2.0
6.3
87
278
R4130
NOMESCO Finland
Speech therapy
2.7
6.3
43
98
61
HP
Catheterization and pressure measurement of the left side of the heart
5.1
6.3
20
24
SPAT1153
SPAT
Removal of sutures
1.6
6.3
193
787
F70.1
ICD-10 Finland
Mild mental retardation, Significant impairment of behaviour requiring attention or treatment
7.7
6.3
15
12
R10.0
ICD-10 Finland
Acute abdomen
3.1
6.3
35
70
F41.0
ICD-10 Finland
Panic disorder [episodic paroxysmal anxiety]
2.5
6.3
49
121
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
10.0
6.2
13
8
J45.9
ICD-10 Finland
Asthma, unspecified
1.5
6.2
197
811
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
2.1
6.2
69
203
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
6.1
6.2
17
17
WX002
NOMESCO Finland
Sedation and analgesia
1.8
6.2
108
378
DFF00
NOMESCO Finland
Pure tone audiometry
2.3
6.1
57
155
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.2
6.1
65
186
SPAT1215
SPAT
Assessment of need for medical rehabilitation
2.5
6.1
48
119
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
2.4
6.1
51
131
U07
ICPC
Urine symptom/complaint other
2.9
6.1
38
82
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.0
6.0
76
236
AAF50
NOMESCO Finland
Third ventriculostomy
27.5
6.0
9
*
K04.08
ICD-10 Finland
Other specified pulpit
2.0
6.0
79
248
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
309
18
86.84
312.57
2.6
1.2
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
4835
13259
1.91
308.93
2.3
2.7
g/l
66.8
66.4
2.91
4426
12148
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
20242
49039
2.59
307.65
2.4
1.8
u/l
235.5
196.8
2.93
19171
45714
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
24771
87628
1.70
307.65
2.5
2.2
nmol/l
3698.3
75.8
0.50
22629
80046
(3024561) Albumin [Mass/volume] in Serum or Plasma
25291
85572
1.82
307.65
4.9
4.9
g/l
36.2
35.8
13.91
23511
79481
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
1279
793
8.27
307.65
1.1
1.0
—
—
—
0
0
(3044889) 12 lead EKG panel
37620
152655
1.60
307.65
3.7
3.1
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
26378
87283
1.90
307.65
6.4
5.8
mmol/l
1.2
1.2
3.01
24119
79085
(42870588) Differential panel, method unspecified - Blood
21082
73612
1.67
307.65
6.3
6.0
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
20431
73068
1.60
307.65
3.4
3.1
u/l
32.4
33.5
0.78
19386
69525
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
3271
5706
2.99
307.65
4.1
5.3
mmol/l
24.7
24.5
3.12
3055
5317
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
9816
29175
1.82
307.65
1.9
1.7
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
14969
53027
1.55
307.65
2.6
2.5
umol/l
3057.1
4474.0
4.82
13126
46748
(3030467) Casts [#/volume] in Urine by Automated count
16198
57891
1.55
307.65
3.3
2.9
e6/l
0.3
0.4
5.23
12469
42069
(3021960) Folate [Moles/volume] in Serum or Plasma
13331
41955
1.76
307.65
1.6
1.5
nmol/l
20.0
20.4
2.05
11659
36173
(3020564) Creatinine [Moles/volume] in Serum or Plasma
56788
259160
2.09
307.65
17.3
12.4
umol/l
75.3
75.1
0.80
56770
258988
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
19490
63293
1.80
307.65
2.8
2.4
u/l
55.8
59.5
9.20
18086
58409
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
11521
35396
1.78
307.65
1.3
1.2
iu/ml
28.8
34.4
1.44
3391
11235
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
5591
12151
2.45
307.65
2.4
2.3
au/ml
22.7
22.7
0.01
269
1005
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
441
54
41.40
307.65
2.8
2.3
umol/l
28.3
27.8
0.10
320
30
(3037467) Urinalysis macro (dipstick) panel - Urine
39491
157219
1.71
307.65
4.7
3.7
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
10992
30400
1.99
307.65
1.8
1.7
nmol/l
1175.8
1152.5
1.58
8553
22846
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
51559
216417
2.12
307.65
5.2
4.2
mu/l
1.9
2.2
3.41
48263
199395
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
43299
169184
1.93
307.65
7.6
7.0
u/l
76.6
78.0
7.67
41001
159108
(3026008) Bacteria identified in Urine by Culture
17372
59636
1.65
307.65
3.1
2.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
6652
19616
1.79
307.65
1.8
1.6
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
28792
108942
1.61
307.65
6.4
5.7
%
56.8
56.6
1.23
27129
102269
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
1059
924
5.85
307.65
1.6
1.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
22551
86243
1.49
307.65
4.0
3.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
1142
608
9.61
307.65
1.1
1.1
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
1520
1859
4.19
307.65
4.9
6.0
umol/l
370.6
381.8
1.52
1363
1597
(3009261) Glucose [Presence] in Urine by Test strip
28972
112785
1.54
307.65
3.9
3.1
estimate
0.0
0.0
0.66
5648
20718
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
11294
35695
1.72
307.65
3.7
3.2
ng/l
452.7
622.1
0.94
7677
25921
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
2622
2067
6.62
307.65
1.6
1.5
e6/l
1122.6
3113.9
0.54
2152
1605
(3032080) INR in Blood by Coagulation assay
23110
75544
1.85
307.65
8.4
7.6
inr
1.2
1.2
2.64
7068
22578
(3044290) Cell count panel - Cerebral spinal fluid
2446
2009
6.34
307.65
1.5
1.5
—
—
—
0
0
(3009343) pH of Capillary blood
4886
9332
2.77
307.65
3.8
4.6
ph
7.4
7.4
0.39
584
1277
(3035350) Ketones [Presence] in Urine by Test strip
28737
111073
1.56
307.65
3.9
3.1
estimate
0.0
0.0
0.17
5672
20564
(3019069) Monocytes/100 leukocytes in Blood
28458
106395
1.63
307.65
6.9
6.1
%
8.4
8.5
1.68
26839
99869
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
1389
930
7.67
307.65
1.1
1.0
au/ml
28.4
2.9
—
9
7
(3006504) Eosinophils/100 leukocytes in Blood
28302
105794
1.63
307.65
6.6
5.8
%
2.8
2.8
1.02
26568
98745
(3037522) Nuclear Ab [Titer] in Serum
9668
28318
1.85
307.65
1.4
1.3
titre
504.4
546.0
1.17
1839
5627
(3013115) Eosinophils [#/volume] in Blood
31442
115608
1.74
307.65
6.6
6.0
e9/l
0.2
0.2
1.01
28055
101237
(3023410) Appearance of Cerebral spinal fluid
1225
1029
6.09
307.65
1.8
1.9
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
5605
14701
2.01
307.65
2.6
2.7
g/l
10.3
10.7
10.52
5118
13558
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
56656
261710
1.93
307.65
11.3
8.6
u/l
28.1
26.2
33.63
55090
252483
(36304419) Bacteria [Presence] in Urine
15938
56876
1.55
307.65
3.3
2.8
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
38047
147975
1.75
307.65
4.9
3.7
e6/l
1383.0
1093.9
0.50
590
1859
(3002582) Erythrocytes [#/volume] in Urine
17781
63524
1.57
307.65
3.4
2.9
e6/l
67.9
99.0
1.96
13936
47230
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
26654
107804
1.43
307.65
4.2
3.8
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
2977
2288
6.83
307.65
1.5
1.4
mg/l
476.6
510.6
0.89
2835
2182
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
22535
68475
2.02
307.65
3.7
2.8
ng/l
64.1
64.3
0.00
14021
40821
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
15212
50534
1.68
307.65
2.3
2.2
mg/l
2.9
2.9
0.34
13092
43188
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
4943
9466
2.77
307.65
3.8
4.6
kpa
5.2
5.1
15.10
4593
8787
(3026782) Osmolality of Urine
11773
39725
1.61
307.65
2.9
2.6
mosm/kgh2o
546.7
554.8
2.90
10220
33565
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
10820
33174
1.78
307.65
1.3
1.2
u/ml
9.0
12.7
4.91
4300
13197
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
14679
47204
1.74
307.65
3.1
2.8
ng/l
1208.8
1420.7
6.01
12191
40192
(3013826) Glucose [Moles/volume] in Serum or Plasma
35218
120690
2.07
307.65
5.1
4.2
mmol/l
6.6
6.6
0.33
33016
110112
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
44958
179146
1.93
307.65
4.4
3.7
pmol/l
14.6
14.6
0.63
41634
163189
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
1181
628
9.63
307.65
1.1
1.0
mg/l
252.8
248.0
0.13
1036
557
(3016018) Differential panel - Cerebral spinal fluid
1297
1130
5.88
307.65
1.6
1.6
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
789
404
9.94
307.65
1.1
1.0
u/l
1.0
1.1
1.22
337
188
(40761511) CBC panel - Blood by Automated count
56091
258762
1.86
307.65
14.8
10.1
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
8031
24644
1.73
307.65
6.4
6.2
mmol/l
1.1
1.1
0.67
7521
23061
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
2623
2063
6.64
307.65
1.5
1.5
e6/l
20.3
25.1
0.46
2057
1500
(3006315) Basophils [#/volume] in Blood
30485
111718
1.73
307.65
6.4
5.7
e9/l
0.0
0.0
4.06
26772
96314
(3018418) pH of Serum or Plasma
17223
56714
1.73
307.65
4.1
4.1
ph
7.4
7.4
0.69
3478
10523
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
5169
11046
2.48
307.65
1.3
1.2
au/ml
46.5
48.9
0.23
159
538
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
28957
97118
1.93
307.65
7.1
6.3
mmol/l
1.2
1.2
1.77
24487
82073
(3000850) Epithelial cells [#/volume] in Urine
12865
42237
1.67
307.65
2.8
2.4
e6/l
5.9
6.0
0.50
11440
36453
(3012516) Albumin [Mass/volume] in Urine
15427
53865
1.59
307.65
3.4
3.2
mg/l
516.9
338.0
3.80
10172
33732
(1002224) Polysomnography panel
3702
6943
2.79
307.65
1.1
1.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
27412
103825
1.58
307.65
3.2
2.7
ug/l
110.4
110.8
0.08
25586
97368
(3027801) Oxygen [Partial pressure] in Arterial blood
6665
19388
1.82
307.65
7.5
7.5
kpa
12.6
13.0
4.96
6355
18471
(3023103) Potassium [Moles/volume] in Serum or Plasma
55746
241615
2.45
307.65
17.3
12.2
mmol/l
4.0
3.9
2.73
54599
233592
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
6711
19728
1.80
307.65
1.8
1.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
13214
46207
1.56
307.65
1.5
1.4
g/l
2.3
2.3
2.10
8327
28611
(3019550) Sodium [Moles/volume] in Serum or Plasma
55656
240687
2.45
307.65
17.2
12.1
mmol/l
139.6
139.6
9.54
54593
233253
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
1214
654
9.51
307.65
1.2
1.1
mg/l
43.5
38.3
1.10
1012
544
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
6670
19397
1.82
307.65
7.5
7.5
kpa
5.1
5.1
1.48
6364
18475
(3021601) Nitrite [Presence] in Urine by Test strip
28732
111676
1.54
307.65
5.2
4.2
estimate
0.0
0.0
0.91
5858
21157
(4027681)
974
470
10.58
307.65
1.3
1.2
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
30007
108181
1.76
307.65
5.8
6.2
umol/l
10.8
11.7
26.38
28328
102296
(3019198) Lymphocytes [#/volume] in Blood
31230
115696
1.71
307.65
6.4
5.7
e9/l
2.0
2.0
0.41
27894
101788
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
720
76
48.23
307.65
2.6
1.8
umol/l
53.8
43.3
1.86
643
41
(3003396) Base excess in Arterial blood by calculation
6701
19365
1.83
307.65
7.5
7.5
mmol/l
1.1
0.8
8.22
5162
15094
(3022096) Basophils/100 leukocytes in Blood
27505
102410
1.63
307.65
6.6
5.9
%
0.7
0.7
0.57
25813
95643
(3015377) Calcium [Moles/volume] in Serum or Plasma
19340
66572
1.67
307.65
3.0
3.5
mmol/l
2.3
2.4
6.32
17025
58760
(3013512) EKG study
15718
54699
1.60
307.65
3.8
3.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
15202
52952
1.59
307.65
1.3
1.3
u/ml
1.4
1.9
4.17
4221
14390
(3022948) Iron [Moles/volume] in Serum or Plasma
9522
31276
1.63
307.65
2.6
2.4
umol/l
13.6
14.2
0.47
8835
29162
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
4738
9035
2.77
307.65
3.8
4.5
mmol/l
1.4
1.6
1.39
3478
6367
(3015736) pH of Urine
22771
85299
1.54
307.65
3.6
2.9
ph
5.8
5.8
0.08
13
63
(3033658) Prothrombin time (PT) actual/Normal
15017
53698
1.54
307.65
4.2
3.9
%
92.1
91.1
4.58
14613
52386
(3018095) Leukocytes [#/volume] in Urine
20657
76497
1.54
307.65
4.0
3.3
e6/l
79.5
95.3
1.61
15035
51250
(3019060) Gas panel - Arterial blood
4020
10138
2.06
307.65
5.1
4.5
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
9934
30218
1.78
307.65
3.6
3.8
mmol/l
0.8
0.8
0.34
9257
28312
(3022313) Gas panel - Capillary blood
3641
6459
2.95
307.65
3.9
5.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
55364
243092
2.25
307.65
15.8
10.9
mg/l
20.8
24.0
87.63
45693
183431
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
955
712
6.84
307.65
1.3
1.2
mmol/l
1.9
2.1
2.58
894
661
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
39165
162329
1.57
307.65
3.5
2.7
u/l
47.3
42.8
17.97
37004
152942
(3009508) Creatinine [Moles/volume] in Urine
17819
62212
1.62
307.65
3.4
3.2
mmol/l
8.0
8.1
0.11
15151
53053
(3013707) Erythrocyte sedimentation rate by Westergren method
42821
164445
1.98
307.65
4.3
3.5
mm/h
11.0
11.0
0.17
40148
152079
(3029937) Albumin [Presence] in Urine by Test strip
16005
58100
1.52
307.65
4.3
3.3
estimate
0.0
0.0
0.10
5644
20341
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
50954
225958
1.72
307.65
4.6
3.7
mmol/l
5.9
5.8
101.45
47177
207975
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
14494
44360
1.84
307.65
2.0
1.7
mg/l
1.0
1.3
7.82
10731
33440
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
23182
78243
1.78
307.65
2.0
1.8
pmol/l
97.0
95.9
2.68
12629
40931
(3007853) Bacteria identified in Skin by Aerobe culture
7833
23749
1.75
307.65
1.9
1.6
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
30346
111255
1.72
307.65
6.4
5.7
e9/l
0.6
0.6
0.74
26665
95969
(3002030) Lymphocytes/100 leukocytes in Blood
29197
110636
1.61
307.65
6.6
5.8
%
28.7
28.9
2.49
27419
103382
(3018677) aPTT in Platelet poor plasma by Coagulation assay
10137
26268
2.12
307.65
2.3
2.2
s
29.6
30.0
7.37
9829
25548
(3019150) Specific gravity of Urine by Refractometry
13506
46786
1.58
307.65
4.2
3.3
kg/l
1.0
1.0
1.74
1980
7241
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
48260
208167
1.72
307.65
5.9
4.6
mmol/mol
39.6
38.5
103.11
45300
193469
(3013650) Neutrophils [#/volume] in Blood by Automated count
33985
130777
1.67
307.65
9.1
9.0
e9/l
4.1
4.0
7.74
30059
113598
(3020682) Albumin/Creatinine [Ratio] in Urine
16057
56935
1.56
307.65
4.2
3.9
mg/mmol
10.4
9.3
1.20
10524
36120
(40768797) Stomach Pathology biopsy report
8322
26388
1.68
307.65
1.2
1.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
1362
906
7.71
307.65
1.1
1.0
au/ml
52.3
62.9
—
9
12
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
50030
224453
1.60
307.65
13.5
10.4
ml/min/173m2
87.4
85.8
43.12
41978
180073
(3023368) Bacteria identified in Blood by Culture
15558
51111
1.71
307.65
4.4
4.0
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
12569
39030
1.78
307.65
1.7
1.6
pmol/l
35348173.3
36785916.6
0.08
10640
32627
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
2629
2042
6.72
307.65
1.4
1.3
mmol/l
3.6
3.7
0.74
2471
1932
(3036481) Cortisol [Moles/volume] in Serum or Plasma
7158
16912
2.28
307.65
2.2
2.3
nmol/l
364.0
387.1
15.47
6578
15720
(3016502) Oxygen saturation in Arterial blood
5909
17370
1.79
303.97
8.0
7.9
%
95.7
95.9
0.91
5670
16699
(3004789) Transferrin [Mass/volume] in Serum or Plasma
8749
28752
1.62
300.09
2.6
2.4
g/l
2.4
2.4
6.62
8093
26684
(3021589) Normoblasts [#/volume] in Blood
25425
103967
1.39
293.97
10.1
8.6
e9/l
0.0
0.0
0.54
20939
84833
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
4879
13746
1.85
286.43
2.4
2.1
ug/l
6.6
8.2
5.24
4212
12087
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
9951
34119
1.56
284.28
2.7
3.1
mmol/l
2.4
2.4
11.96
8589
29897
(3008152) Bicarbonate [Moles/volume] in Arterial blood
3826
9956
2.00
282.68
7.3
6.6
mmol/l
24.6
24.3
4.59
3576
9214
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
655
534
6.23
278.95
1.2
1.0
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
14011
51961
1.46
274.69
4.6
4.1
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
8085
26585
1.61
274.44
2.7
2.5
%
23.0
23.2
0.60
6854
23132
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
620
487
6.46
272.20
1.3
1.2
%
69.2
66.0
0.24
74
58
(3044640) Blood type and Crossmatch panel - Blood
17947
70011
1.41
265.78
2.5
2.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
8722
29422
1.57
265.42
2.3
2.6
ug/g
119.8
135.4
3.06
6780
23344
(3011397) Hemoglobin [Presence] in Urine by Test strip
13596
50431
1.46
264.65
3.9
3.1
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
7033
22541
1.64
263.34
21.2
21.4
inr
1.3
1.3
1.93
1090
3296
(3004588) Protein electrophoresis panel - Serum or Plasma
3864
10344
1.94
263.13
2.1
2.5
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
3016
7398
2.11
259.57
1.3
1.2
u/ml
0.8
0.9
0.14
277
554
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
617
512
6.12
258.90
1.2
1.0
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
2387
5317
2.31
257.93
2.4
2.3
ug/l
603.2
472.1
0.60
2196
4936
(3002173) Hemoglobin [Mass/volume] in Arterial blood
5421
16281
1.74
257.04
8.4
8.2
g/l
123.7
120.7
18.00
5228
15670
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
610
506
6.12
256.05
1.6
1.6
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
8993
30796
1.55
255.39
1.9
1.7
%
1.5
1.4
20.02
7957
27599
(3042936) Bacteria identified in Isolate by Culture
8413
28515
1.56
249.35
2.2
1.8
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
51681
240673
1.46
247.85
4.9
4.0
mmol/l
2.8
2.8
77.55
48264
223598
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
7064
23125
1.61
241.64
7.1
5.7
—
—
—
0
0
(3012544) pH of Venous blood
5839
18209
1.68
241.13
4.6
4.2
ph
7.4
7.4
1.44
45
69
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
49057
226560
1.41
241.08
4.0
3.4
mmol/l
1.4
1.2
176.71
45628
210301
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
3049
7728
2.04
240.71
1.9
2.0
u/l
38.9
39.9
1.76
2743
6917
(3021447) Carbon dioxide [Partial pressure] in Venous blood
5680
17632
1.68
238.42
4.6
4.2
kpa
5.9
5.8
7.13
5495
17122
(3002032) Base excess in Venous blood by calculation
5654
17577
1.68
235.91
4.6
4.2
mmol/l
1.9
1.7
4.83
4578
14182
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
50957
237246
1.43
234.62
4.5
3.7
mmol/l
4.6
4.7
136.90
47905
221916
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
50565
235542
1.42
224.63
4.4
3.7
mmol/l
1.4
1.5
270.92
47303
219541
(3007461) Platelets [#/volume] in Blood
58672
282106
1.73
224.44
23.4
16.0
e9/l
255.8
254.1
8.25
57724
273695
(3041096) Erythrocytes [Presence] in Urine by Automated
16088
63050
1.38
223.31
3.4
2.8
—
—
—
0
0
(40761535) Cells panel - Urine sediment
4914
14925
1.71
222.41
3.7
3.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
14685
56713
1.40
222.15
6.9
7.0
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
4130
11954
1.79
220.18
1.9
1.8
g/l
1.3
1.3
0.77
3827
10950
(3035941) MCH [Entitic mass]
58686
282429
1.71
217.74
23.2
15.9
pg
30.2
30.2
1.01
58146
278221
(3024731) MCV [Entitic volume]
58690
282468
1.71
217.33
23.3
15.9
fl
90.5
90.4
3.59
58148
278243
(3010813) Leukocytes [#/volume] in Blood
58708
282586
1.71
217.12
23.4
16.0
e9/l
6.9
6.7
65.09
57641
273397
(3026361) Erythrocytes [#/volume] in Blood
58694
282508
1.71
216.90
23.3
16.0
e12/l
4.5
4.5
0.31
57597
273352
(4010399)
4464
13291
1.74
216.33
1.4
1.4
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
7018
23524
1.57
215.60
7.1
7.3
mmol/l
104.5
104.6
0.58
6853
23085
(3000963) Hemoglobin [Mass/volume] in Blood
58703
282645
1.71
214.60
23.5
16.1
g/l
136.1
136.2
0.55
58157
278473
(3005322) IgE [Units/volume] in Serum or Plasma
4675
14179
1.71
212.20
1.4
1.3
u/ml
232.7
269.8
0.75
4336
13107
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
9757
35287
1.46
209.44
2.9
2.6
e6/l
1.1
1.2
0.50
5570
19185
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
4483
13488
1.73
209.21
1.7
1.6
—
—
—
0
0
(3019225) pH of Specimen
5627
18006
1.63
208.85
4.4
3.8
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
4705
14433
1.69
204.69
4.1
3.6
kpa
4.7
4.7
0.82
4545
13955
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
358
192
9.43
204.47
1.1
1.0
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
295
110
13.56
202.30
1.1
1.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
7038
23932
1.54
202.03
1.5
1.4
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
346
179
9.78
201.76
1.1
1.0
mg/g
7.0
6.3
0.43
331
172
(3015235) Bicarbonate [Moles/volume] in Capillary blood
1805
3996
2.31
197.04
3.2
3.3
mmol/l
24.6
24.2
2.25
1581
3535
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
574
598
4.87
194.94
1.1
1.1
nmol/l
8.5
1.2
1.73
123
90
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
4075
12173
1.73
194.42
8.1
8.0
mmol/l
24.7
24.6
0.75
4042
12080
(3014111) Lactate [Moles/volume] in Serum or Plasma
5183
16563
1.63
192.54
7.2
7.3
mmol/l
1.4
1.3
0.20
4953
15959
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
4382
13396
1.70
192.53
4.0
4.1
ng/l
88.1
88.3
0.05
3817
11734
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
4539
14028
1.68
191.58
3.0
2.7
ng/l
169.2
218.8
9.37
4047
12763
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
13607
52974
1.37
190.99
2.4
2.2
—
—
—
0
0
(3020891) Body temperature
2474
6356
2.00
187.40
4.8
4.6
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
453
387
5.93
185.49
1.1
1.1
ng/l
300.1
716.6
0.63
96
77
(3020779) Urea [Moles/volume] in Serum or Plasma
5217
16858
1.61
185.00
8.5
7.5
mmol/l
8.9
9.2
2.05
4989
16095
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
13675
53510
1.37
184.98
1.8
1.6
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
397
304
6.61
177.95
1.2
1.1
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
4368
13659
1.66
175.77
3.1
3.5
pmol/l
4.5
4.6
3.22
3908
12327
(3023183) Ammonium ion [Moles/volume] in Plasma
1558
3412
2.33
174.00
2.9
2.7
umol/l
33.4
35.3
1.87
1350
2888
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
2290
5907
1.99
171.32
1.9
1.8
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
9088
33612
1.42
169.22
3.1
2.7
e6/l
3.1
3.0
0.47
4922
17607
(3010421) pH of Blood
1886
4543
2.12
168.67
4.1
3.6
ph
7.4
7.4
2.53
1616
3847
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
3653
11014
1.71
167.85
1.5
1.5
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
4785
15529
1.60
165.81
3.9
3.7
mmol/l
1.2
1.2
4.10
4214
13489
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
455
444
5.19
164.99
1.0
1.0
ng/l
44.1
34.9
3.43
313
347
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
2329
6131
1.95
164.53
1.7
1.7
g/l
1.2
1.2
5.01
2216
5839
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
451
439
5.20
163.94
1.0
1.0
ng/l
314.6
317.5
0.04
316
345
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
6870
24219
1.48
163.86
2.8
2.9
umol/l
7.3
8.8
7.67
5818
21103
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
452
443
5.17
163.22
1.0
1.0
ng/l
723.5
830.5
3.36
310
326
(3002385) Erythrocyte distribution width [Ratio]
45415
211058
1.30
162.44
18.6
13.6
%
13.6
13.6
1.03
44673
206265
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
2266
5961
1.95
160.34
1.7
1.7
g/l
0.2
0.2
1.60
2155
5659
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
317
207
7.74
159.84
1.1
1.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
5009
16601
1.56
158.53
8.9
8.6
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
316
210
7.61
157.41
1.1
1.1
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
3524
10716
1.69
156.70
3.8
3.5
g/l
131.5
128.9
8.25
3436
10482
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
13992
56102
1.33
156.67
1.7
1.6
mmol/l
1.5
1.3
40.37
11880
48018
(3047181) Lactate [Moles/volume] in Blood
2073
5334
1.99
155.94
6.4
5.0
mmol/l
1.3
1.3
0.51
1836
4673
(36660697) Celiac disease serology panel - Serum
5559
18948
1.52
155.11
1.2
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
1627
3817
2.18
155.08
3.6
3.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
5745
19723
1.51
155.06
3.6
2.9
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
2127
5542
1.96
154.53
4.1
3.9
mmol/l
1.4
1.4
0.69
2091
5442
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
316
217
7.36
153.80
1.1
1.0
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
4137
13192
1.62
153.44
2.5
2.3
u/l
6031.9
6283.4
0.17
1488
5569
(3028626) Oxygen [Partial pressure] in Capillary blood
1879
4696
2.05
152.80
4.5
4.8
kpa
8.8
8.7
1.05
1754
4418
(3028707) Methadone [Presence] in Urine by Screen method
2021
5195
1.99
152.41
3.3
3.0
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
1657
3953
2.14
151.63
4.2
3.7
kpa
8.9
8.8
1.23
1624
3864
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
3391
10299
1.70
151.30
1.7
1.6
—
—
—
0
0
(3012501) Base excess in Blood by calculation
1647
3932
2.14
150.43
4.1
3.7
mmol/l
2.2
2.4
2.26
1091
2522
(3013290) Carbon dioxide [Partial pressure] in Blood
1647
3933
2.14
150.34
4.1
3.7
kpa
5.0
4.9
4.98
1615
3844
(3017446) Testosterone [Moles/volume] in Serum or Plasma
5027
16889
1.54
149.44
2.5
2.0
nmol/l
11.8
12.5
6.53
4425
15206
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
296
193
7.75
149.43
1.1
1.0
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
309
215
7.27
148.99
1.1
1.0
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
6046
21177
1.48
147.80
2.8
2.7
%
1.8
1.7
3.35
5338
18934
(3009445) Proteinase 3 Ab [Units/volume] in Serum
2792
8087
1.77
146.78
1.5
1.6
u/ml
14.9
12.8
0.24
68
271
(3023511) Choriogonadotropin [Units/volume] in Urine
2319
6350
1.87
145.70
1.5
1.3
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
1849
4696
2.01
143.98
4.3
4.2
mmol/l
3.8
3.9
1.60
1731
4417
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
359
319
5.69
142.10
1.3
1.2
%
18.8
22.2
0.26
52
54
(3027273) Bicarbonate [Moles/volume] in Venous blood
2816
8257
1.75
141.96
3.8
3.3
mmol/l
25.2
25.1
1.10
2719
8014
(3017181) Myelocytes/100 leukocytes in Blood
5142
17551
1.52
141.86
4.2
4.2
%
0.9
0.9
0.57
1381
4776
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
39115
179799
1.25
138.27
3.5
3.2
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
2284
6339
1.84
137.58
1.6
1.6
titre
268.1
292.9
0.14
83
273
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
3537
11145
1.63
136.98
9.3
9.5
%
1.4
1.3
3.48
3508
11085
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
2758
8139
1.74
135.88
3.4
3.2
%
1.4
1.3
3.84
2743
8098
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
3532
11157
1.63
135.41
9.4
9.6
%
0.7
0.7
5.73
3500
11102
(3017732) Neutrophils [#/volume] in Blood
4467
14971
1.54
133.55
2.7
2.6
e9/l
4.1
4.1
0.02
3572
11888
(3002179) Metamyelocytes/100 leukocytes in Blood
4714
16007
1.52
132.77
3.9
4.0
%
0.6
0.6
0.41
1007
3481
(3014007) Fractional oxyhemoglobin in Arterial blood
3530
11220
1.62
131.94
9.4
9.7
%
93.9
94.1
1.93
3516
11183
(3021440) Promyelocytes/100 leukocytes in Blood
4890
16773
1.51
131.34
4.2
4.3
%
0.1
0.1
0.05
1283
4440
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
872
1650
2.68
130.45
2.3
2.6
nmol/l
20.6
20.5
0.11
821
1581
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
178
57
15.76
129.87
1.1
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
1339
3122
2.18
129.40
1.1
1.1
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
2008
5455
1.88
129.00
1.3
1.2
u/ml
35.7
37.6
0.10
122
331
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
2682
7984
1.72
128.03
3.3
3.2
%
0.7
0.7
0.37
2568
7687
(3025159) Blasts/100 leukocytes in Blood
4643
15845
1.51
127.54
4.3
4.3
%
0.2
0.2
0.01
1094
3761
(3036489) Thrombin time
2650
7889
1.72
126.46
2.5
2.3
s
21.2
21.5
1.83
2265
6863
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
545
787
3.51
125.51
1.6
1.4
u/l
6.1
5.5
0.69
463
662
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
1668
4304
1.98
124.23
2.1
1.7
pmol/l
187.5
200.7
4.52
1586
4106
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
5601
19977
1.45
123.57
2.6
2.4
u/l
42.9
46.3
0.14
4788
17183
(3021901) Oxygen saturation in Capillary blood
1275
2971
2.18
123.37
2.7
2.9
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
2677
8050
1.70
123.20
1.5
1.4
u/l
8.8
9.4
1.23
2178
6513
(3000570) Elastase.pancreatic [Mass/mass] in Stool
1900
5146
1.89
123.11
1.4
1.4
ug/g
283.1
274.7
0.84
1053
2934
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
6567
24149
1.41
122.73
4.4
3.8
%
31.3
32.5
15.81
4909
16220
(3017143) Hepatitis C virus Ab [Presence] in Serum
8468
32507
1.36
122.35
1.7
1.6
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
5372
19042
1.46
122.30
2.4
2.4
g/l
0.2
0.2
1.05
5002
17778
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
2556
7610
1.72
121.84
4.2
3.8
%
50.7
47.8
6.20
2530
7520
(3025941) Bacteria identified in Stool by Culture
3935
13079
1.55
121.61
1.3
1.2
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
1486
3712
2.04
120.78
2.5
2.3
%
16.9
16.4
3.66
772
1821
(3007930) Methemoglobin/Hemoglobin.total in Blood
2359
6887
1.75
120.33
5.9
4.5
%
0.9
0.9
1.29
2211
6432
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
7214
27077
1.39
119.47
1.7
1.9
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
2387
7009
1.74
119.37
5.8
4.4
%
1.8
1.7
2.85
2235
6547
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
1766
4762
1.89
115.88
1.3
1.3
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
410
508
4.08
115.06
1.1
1.1
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
3118
9937
1.61
114.86
5.0
4.8
mmol/l
24.2
24.0
2.47
2800
9094
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
4833
16997
1.47
114.12
1.2
1.2
iu/ml
120.3
156.4
8.28
1811
6375
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
1841
5070
1.85
113.33
1.3
1.3
u/ml
8.1
10.4
0.73
287
774
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
2370
7049
1.72
113.25
1.9
1.8
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
6167
22755
1.40
112.36
4.0
4.5
u/l
237.2
243.9
1.88
5807
21697
(3023520) Reticulocytes [#/volume] in Blood
4412
15296
1.49
111.75
2.7
2.8
e9/l
71.0
68.9
2.98
3350
11194
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2124
6143
1.77
111.71
2.1
2.3
g/l
7.3
7.4
3.44
1547
4697
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
3091
9896
1.60
111.70
10.3
9.7
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2118
6129
1.77
111.19
2.1
2.3
g/l
3.8
3.9
2.12
1478
4472
(3000492) Spirometry study
6036
22231
1.41
111.05
1.5
1.4
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2119
6138
1.76
110.87
2.1
2.3
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
2292
6812
1.72
109.75
1.9
1.6
nmol/l
37.3
42.9
20.49
2226
6699
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
145
42
17.42
109.72
3.5
3.8
umol/l
41.4
44.6
0.33
125
27
(3021387) Prolactin [Units/volume] in Serum or Plasma
3224
10478
1.58
109.41
1.7
1.6
mu/l
308.4
315.2
0.36
2906
9433
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
1807
5008
1.84
109.04
1.3
1.3
u/ml
6.8
7.2
0.07
190
497
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
2963
9450
1.61
108.68
9.5
10.1
mmol/l
24.2
24.2
0.39
2783
8851
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
2554
7849
1.67
108.26
2.0
1.9
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
2212
6561
1.72
106.63
2.1
1.9
ug/l
2.3
2.4
0.03
1955
5843
(3011412) CD3 cells [#/volume] in Blood
879
1864
2.39
105.09
2.9
2.3
e9/l
1.3
1.2
1.70
493
1165
(3018572) Chloride [Moles/volume] in Blood
1410
3640
1.97
104.79
7.8
6.1
mmol/l
105.2
105.2
0.13
1269
3250
(3039000) Anion gap in Blood
1409
3640
1.97
104.50
7.8
6.1
mmol/l
11.2
11.3
0.59
1268
3250
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
1997
5786
1.76
104.33
2.1
2.4
g/l
3.0
3.1
7.99
1515
4607
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
371
469
4.00
101.68
1.1
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
2806
8978
1.60
101.43
3.8
2.9
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
1535
4138
1.89
100.72
1.2
1.2
u/ml
41.0
45.1
0.38
164
363
(3013139) Helicobacter pylori Ag [Presence] in Stool
4117
14365
1.47
100.60
1.2
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
2660
8424
1.62
100.21
1.1
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
21399
94182
1.22
99.93
2.1
2.0
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
3143
10388
1.55
98.95
2.8
2.5
e6/l
0.3
0.3
0.27
3053
10080
(44816559) Phosphatidylethanol [Mass/volume] in Blood
1574
4304
1.86
98.93
1.4
1.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
1225
3069
2.03
98.74
1.7
1.6
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
1133
2768
2.08
97.51
2.0
1.7
mmol/l
1.7
1.8
0.26
1110
2698
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
1960
5768
1.73
97.01
2.1
2.3
g/l
10.2
10.5
1.72
1622
4898
(3006184) Hemoglobin [Mass/volume] in Capillary blood
1536
4202
1.86
96.40
2.2
2.1
g/l
132.3
130.2
2.45
1152
3042
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
684
1339
2.59
96.08
3.1
2.3
e6/l
522.9
533.7
0.19
571
1087
(3022145) Colonoscopy Study observation
6320
24003
1.36
95.74
1.3
1.4
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
1815
5244
1.76
95.64
2.0
2.0
mg/l
10.8
10.8
0.06
1692
4906
(40761536) Microorganisms panel - Urine sediment
5286
19503
1.40
95.40
4.1
3.3
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
765
1591
2.44
95.27
1.6
1.3
promille
1.2
1.5
6.01
587
1225
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
865
1908
2.30
94.98
1.4
1.3
nmol/l
27.3
30.3
—
7
22
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
2260
6976
1.65
94.02
1.7
1.6
iu/ml
12.3
4.6
0.47
460
1533
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
667
1307
2.59
93.52
3.1
2.4
e9/l
0.2
0.2
0.15
570
1089
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
548
965
2.88
93.20
1.7
1.9
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
1460
3972
1.87
93.17
1.2
1.2
u/ml
31.1
3.7
1.88
26
40
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
2853
9353
1.56
92.94
1.1
1.1
u/ml
13.4
12.8
0.02
43
130
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
2002
6003
1.70
92.70
1.2
1.2
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
3439
11801
1.49
90.89
1.1
1.1
titre
240.1
198.5
0.29
74
368
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
14586
62203
1.24
90.15
4.4
4.6
ug/l
3.0
3.3
0.39
13093
56272
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
1473
4066
1.84
89.90
1.3
1.2
u/ml
3.0
6.1
1.19
113
301
(1001926) Buprenorphine [Presence] in Urine by Screen method
3108
10467
1.52
89.70
2.7
2.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
1016
2462
2.10
89.28
1.6
1.6
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
160
91
8.87
88.44
1.1
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
159
91
8.82
87.56
1.1
1.0
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
1292
3445
1.91
87.52
1.2
1.2
titre
111.6
145.9
0.29
19
74
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
247
253
4.93
85.62
1.3
1.2
nmol/l
134.6
109.7
0.88
192
179
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
4465
16291
1.41
85.46
2.6
2.6
ml/min/173m2
71.4
68.7
3.58
1756
6033
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
2661
8775
1.55
84.33
2.0
1.7
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
1204
3181
1.92
83.77
1.2
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
2517
8219
1.56
83.23
1.6
1.7
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
1002
2483
2.05
83.14
1.2
1.3
nmol/l
0.2
0.2
0.41
57
141
(3052851) Hemolysis interference index of Serum or Plasma
1924
5900
1.66
81.94
3.2
3.1
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
1758
5282
1.69
80.73
2.2
2.4
g/l
0.7
1.0
2.89
1519
4572
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
997
2500
2.02
80.19
1.2
1.3
nmol/l
2.1
0.7
0.62
969
2390
(3024869) Neuronal Ab [Presence] in Serum
157
102
7.77
79.66
1.1
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
798
1842
2.20
79.01
1.6
1.7
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
1596
4700
1.73
78.70
2.1
2.3
g/l
0.0
0.0
1.53
1448
4329
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
145
86
8.51
78.13
1.4
1.2
%
58.5
55.1
0.18
72
33
(1175426) CD3 cells/100 lymphocytes in Blood
698
1529
2.31
77.90
2.6
2.0
%
73.9
71.8
2.63
673
1478
(3009542) Hematocrit [Volume Fraction] of Blood
49361
237382
1.22
77.87
16.5
11.9
%
40.2
40.1
0.29
36429
186038
(4062490)
850
2038
2.11
76.75
1.4
1.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
1049
2725
1.95
76.60
1.3
1.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
2447
8094
1.54
76.39
1.7
1.7
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
848
2037
2.11
76.22
1.3
1.4
g/l
0.4
0.4
1.89
581
1438
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
212
210
5.10
76.04
1.3
1.2
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
848
2041
2.11
75.85
1.3
1.4
g/l
6.5
7.0
3.03
578
1438
(3028192) IgG subclass 2 [Mass/volume] in Serum
847
2039
2.11
75.72
1.3
1.4
g/l
2.9
3.0
0.91
580
1434
(3003181) Sodium [Moles/volume] in Urine
1031
2686
1.95
74.68
1.5
1.5
mmol/l
65.8
62.7
1.14
839
2094
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
1322
3740
1.80
74.61
1.4
1.3
u/l
20.9
24.1
2.97
1098
3135
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
684
1515
2.29
74.50
2.6
2.0
%
13.2
13.0
0.16
362
764
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
1758
5398
1.66
74.45
1.4
1.5
iu/ml
10.8
13.2
0.31
36
129
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
903
2248
2.04
74.06
1.2
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
3698
13373
1.42
74.03
1.1
1.0
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
917
2303
2.02
73.47
1.9
1.7
%
90.5
90.0
1.18
903
2268
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
1611
4850
1.69
73.41
2.0
2.2
g/l
38.5
37.4
8.47
1385
4196
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
1511
4475
1.72
73.02
1.7
1.6
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
958
2456
1.98
72.59
1.5
1.7
mu/l
64.6
66.5
0.09
866
2219
(4306422)
1195
3310
1.83
72.14
1.2
1.2
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
1219
3398
1.82
72.14
1.5
1.6
g/l
0.7
0.8
2.05
894
2618
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
226
251
4.55
72.06
1.1
1.0
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
1853
5821
1.62
71.81
2.7
2.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
1434
4211
1.73
71.40
1.4
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
2067
6688
1.57
70.94
1.4
1.3
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
2107
6874
1.56
69.79
3.1
3.5
g/l
0.3
0.3
0.08
937
3367
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
149
109
6.90
69.46
1.1
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
2714
9375
1.48
69.01
1.8
1.8
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
1462
4359
1.70
68.99
2.1
2.3
g/l
0.0
0.0
0.08
1319
4003
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
439
812
2.73
68.66
2.9
1.9
umol/l
156.4
139.9
0.41
230
398
(3016879) Cocaine [Presence] in Urine
3531
12833
1.41
68.57
2.6
2.0
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
792
1937
2.07
68.06
13.2
4.9
mmol/l
7.3
7.1
0.52
661
1577
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
1449
4327
1.70
67.99
1.8
1.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
9150
38092
1.24
67.57
2.2
2.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
2688
9313
1.47
67.31
1.3
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
13751
59718
1.20
67.14
2.0
2.0
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
2805
9821
1.46
66.59
2.4
2.3
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
144
107
6.79
66.36
1.2
1.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
121
70
8.72
66.28
1.1
1.1
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
1140
3200
1.81
65.99
1.1
1.1
%
118.1
116.2
1.16
1050
2875
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
636
1443
2.23
65.64
2.7
2.0
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
1212
3482
1.77
65.03
1.3
1.2
u/ml
3.6
3.4
0.10
414
1204
(3000764) Benzodiazepines [Presence] in Urine
3740
13855
1.38
64.83
2.6
2.0
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
878
2278
1.95
64.39
1.4
1.4
pmol/l
323.4
329.1
0.10
674
1790
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
2166
7240
1.52
64.36
3.1
2.6
%
94.9
91.2
10.78
2013
6763
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
1362
4060
1.70
64.32
1.3
1.3
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
1428
4314
1.68
64.24
2.1
2.3
g/l
0.0
0.0
0.00
1312
3998
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
1362
4062
1.70
64.20
1.3
1.3
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
513
1072
2.42
63.43
2.8
2.5
e9/l
0.3
0.4
0.57
496
1053
(3028300) Cannabinoids [Presence] in Urine
3763
14003
1.38
63.43
2.6
2.0
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
3589
13255
1.39
63.32
1.4
1.3
iu/l
23.2
25.7
4.49
3078
11275
(3004616) Nuclear Ab [Presence] in Serum
869
2265
1.94
62.92
1.3
1.3
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
1169
3357
1.77
62.82
1.3
1.2
u/ml
4.2
3.8
0.57
513
1538
(3014765) Yersinia sp identified in Stool by Organism specific culture
1931
6326
1.55
62.77
1.2
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
1917
6273
1.56
62.62
1.2
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
1936
6350
1.55
62.60
1.2
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
3746
13979
1.37
62.02
2.5
2.0
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
696
1685
2.09
61.43
1.5
1.6
mosm/kgh2o
281.3
280.5
0.34
540
1344
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
857
2254
1.93
60.49
7.5
5.8
mg/l
11.2
11.3
0.22
786
2075
(3022621) pH of Urine by Test strip
3741
14015
1.37
60.40
3.1
2.6
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
218
275
4.00
60.14
1.1
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
1102
3152
1.77
60.02
1.5
1.5
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
461
944
2.47
59.47
1.1
1.1
miu/ml
1539.8
1419.4
1.23
461
944
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
2033
6825
1.52
59.17
1.1
1.1
u/ml
4.0
5.6
1.25
235
1058
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
1140
3310
1.75
59.04
1.6
1.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
3677
13792
1.36
58.88
2.4
2.0
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
1854
6113
1.54
58.56
1.2
1.3
titre
101.4
115.9
0.33
171
570
(3034770) Mitochondria Ab [Titer] in Serum
1816
5966
1.55
58.29
1.2
1.3
titre
696.2
1084.5
1.91
58
166
(3003338) MCHC [Mass/volume]
45967
221226
1.17
58.14
19.9
13.8
g/l
333.1
333.0
1.76
45672
219346
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
1982
6645
1.52
58.03
3.0
2.6
%
174.7
184.5
5.25
1893
6293
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
9911
42235
1.22
57.53
2.4
2.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
5287
20979
1.29
57.31
1.4
1.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
1178
3497
1.71
56.48
3.2
3.3
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
589
1380
2.16
56.42
1.2
1.1
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
2432
8558
1.45
56.10
1.8
1.8
g/l
1.5
1.5
0.25
2090
7343
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
1764
5809
1.54
56.02
1.8
1.6
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
1354
4187
1.64
55.79
2.4
2.5
ug/min
135.9
98.3
1.54
848
2548
(3011048) Pyruvate [Moles/volume] in Blood
112
76
7.43
55.25
1.4
1.4
umol/l
89.1
84.5
0.46
99
71
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
122
93
6.61
55.19
1.1
1.1
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
410
828
2.50
54.44
3.0
2.1
%
10.2
12.8
2.67
392
774
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
684
1727
2.00
54.15
1.7
1.8
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
624
1524
2.07
53.92
3.3
3.1
mu/l
27.9
24.7
1.12
585
1424
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
1144
3417
1.70
53.66
1.1
1.1
—
—
—
0
0
(4198724)
559
1309
2.16
53.65
2.6
2.4
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
541
1254
2.18
53.21
3.0
2.8
ug/l
29.3
26.9
—
8
19
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
884
2456
1.82
52.95
1.1
1.1
iu/ml
1.4
2.1
1.05
15
52
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
5982
24339
1.26
52.82
2.1
2.0
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
1585
5170
1.56
52.48
3.0
3.4
mg/l
48.7
45.2
0.16
1267
4213
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
296
512
2.92
52.15
3.3
3.0
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
747
1980
1.91
51.62
2.6
2.5
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
1583
5184
1.55
51.52
3.0
3.4
mg/l
46.6
74.7
1.24
1263
4218
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
605
1487
2.06
51.46
3.2
2.4
e6/l
839.2
610.5
9.47
286
488
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
98
61
8.10
51.31
1.0
1.0
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
1034
3041
1.72
51.27
1.4
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
1779
5997
1.51
50.76
4.3
3.3
u/ml
0.4
0.3
2.09
1041
3240
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
1539
5027
1.55
50.65
2.9
3.4
ratio
2.3
4.3
0.82
137
422
(3000060) B lymphocytes [#/volume] in Blood
334
632
2.67
50.29
3.0
2.0
e6/l
182.6
897.0
1.21
189
351
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
120
101
5.99
50.12
1.1
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
11400
49784
1.19
49.88
4.0
3.9
%
21.9
21.9
0.01
4897
23154
(3039162) Centromere protein B Ab [Units/volume] in Serum
888
2525
1.78
49.39
1.3
1.2
u/ml
57.0
51.9
0.21
65
145
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
607
1524
2.01
48.84
1.1
1.1
mg/l
284.0
292.0
1.55
541
1371
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
11189
48899
1.18
48.31
1.7
1.7
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
4834
19365
1.28
48.25
1.9
1.9
—
—
—
0
0
(4034850)
1885
6513
1.47
47.71
10.7
8.0
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
1060
3215
1.67
47.05
1.6
1.8
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
921
2690
1.73
46.81
1.5
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
1482
4894
1.54
46.48
1.4
1.4
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
426
946
2.28
46.36
2.0
2.2
umol/l
1.9
1.9
0.53
397
902
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
387
827
2.36
45.83
1.6
1.6
nmol/l
3.0
6.4
0.59
310
696
(40760888) Immunoglobulin light chains.free panel - Serum
1211
3840
1.60
45.20
3.1
3.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
3518
13624
1.32
45.20
1.4
1.4
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
1348
4390
1.56
44.96
1.7
1.6
e6/l
13391.5
13430.3
0.01
967
3186
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
340
691
2.49
44.69
2.4
3.0
ug/l
1.2
1.3
0.63
311
663
(3024928) Oxygen saturation in Venous blood
1240
3967
1.59
44.62
4.0
3.9
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
695
1897
1.85
44.08
2.7
2.2
%
44.4
37.8
3.51
128
175
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
1048
3225
1.65
44.06
1.8
1.7
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
380
823
2.33
43.74
2.9
1.9
%
27.3
29.1
1.74
367
780
(4268621)
805
2309
1.76
43.55
2.3
2.3
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
1646
5641
1.48
43.38
1.9
2.0
iu/l
9.3
18.8
0.41
600
2184
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
1575
5353
1.49
43.22
1.3
1.3
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
422
965
2.21
42.98
1.2
1.1
u/ml
14.9
13.9
0.04
54
87
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
801
2304
1.76
42.94
1.5
1.4
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
88
61
7.27
42.84
1.0
1.0
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
526
1319
2.02
42.55
1.2
1.2
ratio
1.1
1.1
0.82
191
461
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
533
1344
2.00
42.47
11.1
12.1
mmol/l
0.6
0.6
1.14
484
1250
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
74
40
9.32
42.33
1.1
1.0
u/l
4.3
2.4
—
13
10
(3001186) Copper [Moles/volume] in Serum or Plasma
243
426
2.88
41.99
1.4
1.2
umol/l
16.6
16.9
0.37
209
384
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
196
301
3.29
41.74
1.6
1.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
864
2562
1.71
41.69
1.6
1.5
—
—
—
0
0
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
81
52
7.85
41.61
1.3
1.0
%
21.0
13.3
—
26
10
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
1491
5051
1.50
41.57
1.3
1.3
u/ml
259.7
248.4
0.79
940
3248
(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid
71
37
9.67
41.48
1.5
1.4
%
31.6
38.8
0.39
48
24
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
744
2120
1.78
41.18
2.1
1.9
mg/l
24.6
27.3
0.62
208
549
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
363
794
2.31
40.93
1.9
2.4
umol/l
28.0
28.0
0.02
352
774
(3044927) Protein electrophoresis panel - Urine
543
1401
1.96
40.65
1.2
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
1512
5172
1.48
40.23
1.5
1.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
1083
3443
1.59
40.04
1.5
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
2452
9173
1.36
39.64
1.2
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
1790
6360
1.43
39.15
1.2
1.1
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
399
929
2.17
39.00
1.0
1.1
%
95.6
96.3
0.16
340
710
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
911
2799
1.65
38.59
1.2
1.3
u/l
33.7
37.3
0.29
807
2439
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
594
1610
1.87
38.56
1.4
1.3
nmol/l
1.5
1.3
3.92
537
1455
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
350
775
2.28
38.45
1.1
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
1179
3864
1.55
38.30
1.1
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
279
556
2.53
38.23
7.6
13.8
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
1939
7022
1.40
38.13
3.5
2.7
g/l
3.5
3.6
3.08
1844
6705
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
835
2519
1.68
37.90
1.5
1.4
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
294
608
2.44
37.41
2.6
2.3
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
551
1472
1.89
37.37
1.2
1.2
u/ml
48.9
45.2
0.09
26
59
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
540
1437
1.90
37.06
1.2
1.2
u/ml
48.2
44.8
0.11
42
99
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
70
43
8.20
37.05
1.1
1.0
—
—
—
0
0
(44790049)
739
2172
1.72
36.86
1.6
1.6
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
538
1433
1.90
36.82
1.2
1.2
u/ml
70.6
68.3
0.05
28
62
(44790047)
739
2173
1.72
36.80
1.6
1.6
—
—
—
0
0
(44806118)
739
2173
1.72
36.80
1.6
1.6
—
—
—
0
0
(4146454)
597
1646
1.83
36.80
2.7
2.8
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
1487
5162
1.46
36.77
1.4
1.5
u/ml
20.0
19.8
0.01
33
95
(44790048)
739
2174
1.72
36.75
1.6
1.6
—
—
—
0
0
(4094501)
1471
5099
1.46
36.65
1.1
1.1
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
801
2412
1.68
36.62
1.2
1.1
%
96.3
94.6
0.88
757
2251
(3016650) Hepatitis A virus Ab [Presence] in Serum
1196
3975
1.52
36.50
1.1
1.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
299
631
2.39
36.50
3.1
2.6
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
594
1642
1.83
36.32
2.1
2.0
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
390
927
2.12
36.30
1.6
1.7
nmol/l
1.3
1.2
0.78
294
758
(3016228) CD19 cells/100 cells in Blood
329
728
2.28
36.24
2.2
2.1
%
8.2
9.3
0.81
317
719
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
591
1634
1.83
36.12
1.1
1.1
u/ml
57.6
66.9
—
7
25
(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid
63
34
9.34
36.11
1.6
1.3
%
10.5
15.3
0.48
45
23
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
821
2506
1.66
35.70
1.4
1.4
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
577
1592
1.83
35.51
3.0
2.5
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
540
1464
1.86
35.09
1.2
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
798
2432
1.66
34.92
1.4
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
804
2456
1.66
34.87
1.4
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
795
2429
1.66
34.46
1.4
1.4
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
1334
4594
1.47
34.37
5.9
5.8
iu/ml
1094.7
1232.2
0.10
180
641
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
795
2431
1.65
34.36
1.4
1.4
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
534
1453
1.86
34.33
1.2
1.2
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
416
1040
2.02
34.05
1.7
1.5
umol/l
21.4
26.6
2.83
399
998
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
514
1385
1.88
34.04
1.2
1.2
u/ml
7.8
11.9
0.41
30
108
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
1199
4053
1.50
33.84
2.6
2.0
nmol/l
0.9
0.8
10.37
995
3452
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
1060
3495
1.54
33.58
1.1
1.1
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
101
109
4.67
33.49
1.1
1.0
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
312
699
2.25
33.47
1.1
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
796
2456
1.64
33.25
1.4
1.4
—
—
—
0
0
(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid
55
27
10.26
33.25
1.1
1.1
mg/l
0.1
0.1
0.08
47
22
(21494814) CD8 cells/100 lymphocytes in Specimen
318
721
2.23
33.19
2.2
2.0
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
1080
3587
1.52
33.10
1.1
1.1
iu/ml
9005.5
839.8
0.51
276
845
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
1709
6218
1.39
32.73
5.3
4.7
mg/l
1.4
1.4
1.82
1597
5815
(3047007) Chlamydophila sp Ab [Presence] in Serum
1063
3530
1.52
32.61
1.2
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
1028
3397
1.53
32.26
1.2
1.1
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
531
1475
1.82
32.05
1.4
1.4
umol/l
11.7
11.6
0.09
504
1406
(40757494) Bilirubin.total [Moles/volume] in Blood
361
876
2.08
31.98
2.2
2.2
umol/l
34.7
64.8
1.85
43
106
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
700
2118
1.67
31.53
1.1
1.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
1204
4154
1.47
30.78
1.6
1.6
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
101
118
4.31
30.75
1.1
1.3
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
168
287
2.95
30.48
3.4
3.6
mmol/l
1.2
1.2
0.17
161
272
(21494755) Public health laboratory ask at order entry panel
5444
32189
0.84
30.24
1.3
1.3
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
294
672
2.21
30.18
1.2
1.1
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
174
306
2.87
30.08
1.7
1.8
mmol/l
0.7
0.3
0.47
163
284
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
1029
3454
1.51
30.07
3.3
3.3
u/ml
975.5
2974.9
0.86
57
209
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
908
2967
1.55
29.99
1.6
1.9
titre
4984.3
3282.5
0.31
23
157
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
1366
4855
1.43
29.89
1.5
1.5
u/ml
107.3
109.0
0.17
297
995
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
7238
31629
1.17
29.72
1.5
1.4
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
441
1184
1.88
29.61
1.2
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
398
1035
1.94
29.33
1.4
1.4
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
1127
3876
1.47
29.29
1.1
1.1
au/ml
8.4
12.7
1.51
65
282
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
534
1531
1.76
29.14
1.3
1.3
u/ml
1.4
1.3
0.08
237
618
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
403
1058
1.92
28.91
1.8
1.8
%
134.5
135.9
0.13
385
995
(3019977) pH of Arterial blood
346
862
2.03
28.69
3.1
2.4
ph
7.4
7.4
0.28
98
301
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
390
1015
1.94
28.69
1.4
1.4
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
892
2937
1.54
28.51
1.1
1.1
g/l
1.5
1.5
1.42
805
2662
(3004809) Band form neutrophils/100 leukocytes in Blood
957
3209
1.51
28.14
3.2
3.3
%
1.3
1.5
0.66
738
2455
(3028433) Virus identified in Specimen by Culture
269
611
2.22
28.06
1.1
1.2
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
375
973
1.95
27.84
1.2
1.2
u/l
290.1
332.4
0.36
338
924
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
153
264
2.92
27.36
3.6
3.1
mmol/l
1.2
1.2
0.05
147
247
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
531
1552
1.73
27.17
1.7
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
531
1552
1.73
27.17
1.7
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
531
1552
1.73
27.17
1.7
1.7
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
57
41
7.00
27.12
1.0
1.0
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
536
1573
1.72
27.05
1.2
1.2
—
—
—
0
0
(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid
50
30
8.40
26.93
1.4
1.1
%
0.7
0.5
0.27
32
19
(3042517) Benzodiazepines panel - Urine
161
290
2.80
26.78
2.8
2.9
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
403
1087
1.87
26.75
1.3
1.4
mmol/l
34.3
35.3
0.31
351
956
(3008757) Leukocyte morphology finding [Identifier] in Blood
669
2098
1.61
26.34
3.7
3.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
689
2180
1.60
26.17
1.7
1.6
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
315
786
2.02
26.07
1.2
1.2
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
205
426
2.43
26.03
1.2
1.2
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
285
686
2.10
25.90
1.5
1.4
pmol/l
14.1
15.0
1.58
240
584
(3042631) Mycobacterium sp identified in Specimen
730
2348
1.57
25.89
2.6
2.6
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
505
1477
1.73
25.82
1.8
2.0
g/24h
0.8
1.1
0.64
34
96
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
2200
8623
1.29
25.74
1.5
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
1011
3502
1.46
25.41
1.6
1.5
—
—
—
0
0
(4024509)
557
1684
1.67
25.28
1.5
1.5
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
884
2984
1.50
25.25
1.3
1.2
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
140
242
2.92
25.02
2.4
2.5
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
337
876
1.94
24.96
1.2
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
560
1702
1.66
24.93
1.1
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
560
1703
1.66
24.88
1.1
1.2
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
540
1628
1.68
24.78
1.4
1.4
e6/l
107734.5
91658.4
0.21
370
1141
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
365
978
1.88
24.76
1.1
1.1
u/ml
7.2
12.8
2.12
71
167
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
560
1706
1.66
24.72
1.1
1.2
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
60
53
5.70
24.23
1.0
1.0
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
553
1691
1.65
24.08
1.1
1.2
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
256
611
2.11
23.81
2.3
2.2
ug/l
76.6
64.3
0.98
248
601
(40759836) Histone Ab [Presence] in Serum by Immunoblot
551
1689
1.65
23.78
1.1
1.2
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
514
1547
1.68
23.76
1.2
1.1
nmol/l
371.7
379.4
0.33
449
1334
(3005570) Glucose [Moles/volume] in Urine
611
1924
1.60
23.72
2.0
1.8
mmol/l
0.9
26.0
—
5
15
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
551
1691
1.65
23.68
1.1
1.2
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
233
537
2.19
23.60
1.1
1.3
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
46
30
7.72
23.49
1.0
1.0
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
705
2305
1.55
23.36
1.6
1.6
%
55.3
56.3
0.24
429
1527
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
1239
4528
1.39
23.22
1.5
1.5
nmol/l
0.4
0.4
1.53
982
3651
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
1571
5962
1.33
23.18
1.1
1.1
u/ml
1.4
2.1
2.14
700
2542
(3008037) Lactate [Moles/volume] in Venous blood
1106
3966
1.41
23.14
3.3
2.8
mmol/l
1.6
1.6
0.07
1088
3879
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
212
479
2.23
22.52
3.4
2.3
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
212
479
2.23
22.52
3.4
2.3
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
409
1177
1.75
22.20
1.5
1.6
ug/l
7.5
7.7
0.09
364
1061
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
254
624
2.05
22.01
1.2
1.2
—
—
—
0
0
(44813793)
542
1692
1.62
21.84
1.1
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
465
1401
1.68
21.48
1.6
1.5
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
495
1517
1.65
21.45
1.4
1.3
umol/l
5.4
5.5
0.33
449
1433
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
2413
9792
1.25
21.30
1.3
1.3
miu/ml
233.8
229.9
0.19
1093
4750
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
604
1951
1.56
21.15
1.1
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
733
2472
1.50
21.12
1.2
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
277
715
1.95
21.03
1.3
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
492
1516
1.64
20.89
1.2
1.3
u/ml
—
39.4
—
0
6
(3044941) Cell count panel - Synovial fluid
843
2933
1.45
20.82
1.4
1.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
654
2162
1.53
20.69
1.1
1.1
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
285
748
1.92
20.65
1.2
1.2
g/l
0.3
0.3
0.30
231
589
(3000034) Microalbumin [Mass/volume] in Urine
531
1674
1.60
20.60
3.0
2.9
mg/l
71.4
53.3
0.50
397
1202
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
246
615
2.02
20.40
1.2
1.2
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
284
749
1.91
20.31
1.1
1.1
%
92.8
91.6
0.23
135
340
(3020491) Glucose [Moles/volume] in Blood
511
1603
1.61
20.24
1.7
1.7
mmol/l
6.5
6.5
0.05
385
1229
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
4825
27923
0.86
20.08
1.7
1.6
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
102
167
3.08
20.00
2.9
3.3
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
209
495
2.13
19.92
1.1
1.1
—
—
—
0
0
(3012565) Volume of 24 hour Urine
330
922
1.81
19.81
2.2
2.3
ml
2034.6
2009.5
0.12
295
831
(3038515) Glucose [Moles/volume] in Venous blood
1026
3734
1.39
19.79
3.4
2.9
mmol/l
7.5
7.5
0.00
1008
3669
(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma
335
941
1.80
19.77
1.5
1.4
mu/l
466.9
657.8
0.99
321
894
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
468
1445
1.64
19.75
2.4
2.4
%
97.0
97.4
0.07
435
1351
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
394
1162
1.71
19.72
1.6
1.5
u/ml
24.5
24.7
0.02
74
223
(3008116) Ketones [Moles/volume] in Urine by Test strip
163
348
2.36
19.71
1.5
1.3
—
—
—
0
0
(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma
340
962
1.78
19.60
1.4
1.4
%
71.6
73.0
0.95
326
915
(3051339) Copper [Moles/volume] in Blood
59
65
4.57
19.31
1.1
1.2
umol/l
16.1
16.8
0.47
54
57
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
285
766
1.88
19.30
1.2
1.2
%
110.7
106.0
0.90
260
695
(3000330) Specific gravity of Urine by Test strip
2506
10324
1.23
19.29
3.4
3.0
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
978
3550
1.39
19.17
1.4
1.4
mmol/l
7.0
6.9
0.49
716
2496
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
481
1508
1.61
19.13
1.5
1.5
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
621
2068
1.52
19.05
2.4
2.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
1725
6819
1.28
18.97
2.4
2.8
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
103
176
2.95
18.89
2.5
2.0
umol/l
1.2
1.3
0.40
94
159
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
33
18
9.23
18.87
1.0
1.1
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
579
1905
1.54
18.78
2.9
3.4
%
57.0
57.7
0.23
371
1179
(3000093) Morphology [Interpretation] in Blood Narrative
568
1865
1.54
18.59
1.2
1.1
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
150
317
2.39
18.56
1.1
1.1
umol/24h
0.7
5.3
0.52
78
160
(3051651) Icteric interference index of Serum or Plasma
401
1210
1.67
18.51
3.7
4.0
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
273
734
1.88
18.50
1.1
1.1
%
93.0
91.4
0.24
136
335
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
291
801
1.83
18.36
1.4
1.5
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
291
801
1.83
18.36
1.4
1.5
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
467
1470
1.60
18.31
1.6
1.4
umol/l
67.1
72.0
1.15
31
129
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
294
813
1.82
18.28
1.9
1.7
%
153.9
159.7
0.38
280
759
(43055514) Macroprolactin [Presence] in Serum or Plasma
267
717
1.88
18.17
1.4
1.3
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
542
1771
1.55
18.15
1.6
1.6
%
31.4
33.2
0.51
318
1172
(3013637) Mi-2 Ab [Presence] in Serum
170
386
2.22
17.98
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
170
386
2.22
17.98
1.1
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
170
386
2.22
17.98
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
170
386
2.22
17.98
1.1
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
428
1328
1.63
17.79
1.1
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
274
749
1.85
17.69
1.3
1.2
—
—
—
0
0
(4015189)
172
396
2.19
17.62
2.3
2.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
508
1648
1.56
17.57
1.1
1.1
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
260
703
1.87
17.36
1.2
1.2
%
107.5
112.0
1.77
231
629
(3038177) Helicobacter pylori Ab [Presence] in Serum
1095
4116
1.35
17.34
1.2
1.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
436
1374
1.60
17.06
1.2
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
3249
19132
0.85
16.79
1.4
1.4
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
696
2437
1.44
16.74
1.4
1.4
mmol/l
11.6
11.8
0.17
162
501
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
1549
6140
1.28
16.72
1.2
1.3
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
333
984
1.71
16.65
1.9
1.9
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
333
985
1.71
16.59
1.9
1.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
333
985
1.71
16.59
1.9
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
333
985
1.71
16.59
1.9
1.9
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
273
763
1.80
16.48
2.1
2.0
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
343
1027
1.69
16.37
1.3
1.2
titre
203.8
505.2
1.21
21
54
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
544
1822
1.51
16.34
1.2
1.3
titre
98.5
211.5
1.45
13
65
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
227
599
1.91
16.33
2.0
2.1
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
1318
5139
1.30
16.18
1.1
1.1
u/ml
2.4
2.6
0.16
371
1344
(3014051) Protein [Presence] in Urine by Test strip
1255
4862
1.31
16.15
2.1
2.0
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
544
1827
1.50
16.14
1.2
1.3
titre
215.0
205.0
0.09
100
312
(3003888) Timothy IgE Ab [Units/volume] in Serum
1382
5426
1.29
16.09
1.1
1.1
u/ml
5.9
6.3
0.40
753
2946
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
104
197
2.66
16.04
1.6
1.7
mg/l
1.7
1.8
0.02
63
142
(3017704) Immunofixation for Urine
287
822
1.76
16.01
1.5
1.6
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
317
935
1.71
15.98
2.1
2.3
ug/l
45.3
276.9
1.28
301
890
(21494890) Protein electrophoresis panel - 24 hour Urine
504
1675
1.52
15.72
2.0
2.2
—
—
—
0
0
(